Dietary Strategies and Novel Pharmaceutical Approaches Targeting Serum ApoA-I Metabolism: A Systematic Overview

The incidence of CHD is still increasing, which underscores the need for new preventive and therapeutic approaches to decrease CHD risk. In this respect, increasing apoA-I concentrations may be a promising approach, especially through increasing apoA-I synthesis. This review first provides insight i...

Full description

Bibliographic Details
Main Authors: Lotte Smolders, Jogchum Plat, Ronald P. Mensink
Format: Article
Language:English
Published: Hindawi Limited 2017-01-01
Series:Journal of Nutrition and Metabolism
Online Access:http://dx.doi.org/10.1155/2017/5415921
id doaj-8b7edfdc59714ad0b7c2e86a56c53cb2
record_format Article
spelling doaj-8b7edfdc59714ad0b7c2e86a56c53cb22020-11-24T22:20:10ZengHindawi LimitedJournal of Nutrition and Metabolism2090-07242090-07322017-01-01201710.1155/2017/54159215415921Dietary Strategies and Novel Pharmaceutical Approaches Targeting Serum ApoA-I Metabolism: A Systematic OverviewLotte Smolders0Jogchum Plat1Ronald P. Mensink2Department of Human Biology and Movement Sciences, School of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University Medical Center, P.O. Box 616, 6200 MD Maastricht, NetherlandsDepartment of Human Biology and Movement Sciences, School of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University Medical Center, P.O. Box 616, 6200 MD Maastricht, NetherlandsDepartment of Human Biology and Movement Sciences, School of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University Medical Center, P.O. Box 616, 6200 MD Maastricht, NetherlandsThe incidence of CHD is still increasing, which underscores the need for new preventive and therapeutic approaches to decrease CHD risk. In this respect, increasing apoA-I concentrations may be a promising approach, especially through increasing apoA-I synthesis. This review first provides insight into current knowledge on apoA-I production, clearance, and degradation, followed by a systematic review of dietary and novel pharmacological approaches to target apoA-I metabolism. For this, a systematic search was performed to identify randomized controlled intervention studies that examined effects of whole foods and (non)nutrients on apoA-I metabolism. In addition, novel pharmacological approaches were searched for, which were specifically developed to target apoA-I metabolism. We conclude that both dietary components and pharmacological approaches can be used to increase apoA-I concentrations or functionality. For the dietary components in particular, more knowledge about the underlying mechanisms is necessary, as increasing apoA-I per se does not necessarily translate into a reduced CHD risk.http://dx.doi.org/10.1155/2017/5415921
collection DOAJ
language English
format Article
sources DOAJ
author Lotte Smolders
Jogchum Plat
Ronald P. Mensink
spellingShingle Lotte Smolders
Jogchum Plat
Ronald P. Mensink
Dietary Strategies and Novel Pharmaceutical Approaches Targeting Serum ApoA-I Metabolism: A Systematic Overview
Journal of Nutrition and Metabolism
author_facet Lotte Smolders
Jogchum Plat
Ronald P. Mensink
author_sort Lotte Smolders
title Dietary Strategies and Novel Pharmaceutical Approaches Targeting Serum ApoA-I Metabolism: A Systematic Overview
title_short Dietary Strategies and Novel Pharmaceutical Approaches Targeting Serum ApoA-I Metabolism: A Systematic Overview
title_full Dietary Strategies and Novel Pharmaceutical Approaches Targeting Serum ApoA-I Metabolism: A Systematic Overview
title_fullStr Dietary Strategies and Novel Pharmaceutical Approaches Targeting Serum ApoA-I Metabolism: A Systematic Overview
title_full_unstemmed Dietary Strategies and Novel Pharmaceutical Approaches Targeting Serum ApoA-I Metabolism: A Systematic Overview
title_sort dietary strategies and novel pharmaceutical approaches targeting serum apoa-i metabolism: a systematic overview
publisher Hindawi Limited
series Journal of Nutrition and Metabolism
issn 2090-0724
2090-0732
publishDate 2017-01-01
description The incidence of CHD is still increasing, which underscores the need for new preventive and therapeutic approaches to decrease CHD risk. In this respect, increasing apoA-I concentrations may be a promising approach, especially through increasing apoA-I synthesis. This review first provides insight into current knowledge on apoA-I production, clearance, and degradation, followed by a systematic review of dietary and novel pharmacological approaches to target apoA-I metabolism. For this, a systematic search was performed to identify randomized controlled intervention studies that examined effects of whole foods and (non)nutrients on apoA-I metabolism. In addition, novel pharmacological approaches were searched for, which were specifically developed to target apoA-I metabolism. We conclude that both dietary components and pharmacological approaches can be used to increase apoA-I concentrations or functionality. For the dietary components in particular, more knowledge about the underlying mechanisms is necessary, as increasing apoA-I per se does not necessarily translate into a reduced CHD risk.
url http://dx.doi.org/10.1155/2017/5415921
work_keys_str_mv AT lottesmolders dietarystrategiesandnovelpharmaceuticalapproachestargetingserumapoaimetabolismasystematicoverview
AT jogchumplat dietarystrategiesandnovelpharmaceuticalapproachestargetingserumapoaimetabolismasystematicoverview
AT ronaldpmensink dietarystrategiesandnovelpharmaceuticalapproachestargetingserumapoaimetabolismasystematicoverview
_version_ 1725776593794629632